Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hepatic energy state is regulated by glucagon receptor signaling in mice
Eric D. Berglund, Robert S. Lee-Young, Daniel G. Lustig, Sara E. Lynes, E. Patrick Donahue, Raul C. Camacho, M. Elizabeth Meredith, Mark A. Magnuson, Maureen J. Charron, David H. Wasserman
Eric D. Berglund, Robert S. Lee-Young, Daniel G. Lustig, Sara E. Lynes, E. Patrick Donahue, Raul C. Camacho, M. Elizabeth Meredith, Mark A. Magnuson, Maureen J. Charron, David H. Wasserman
View: Text | PDF
Research Article Metabolism

Hepatic energy state is regulated by glucagon receptor signaling in mice

  • Text
  • PDF
Abstract

The hepatic energy state, defined by adenine nucleotide levels, couples metabolic pathways with energy requirements. This coupling is fundamental in the adaptive response to many conditions and is impaired in metabolic disease. We have found that the hepatic energy state is substantially reduced following exercise, fasting, and exposure to other metabolic stressors in C57BL/6 mice. Glucagon receptor signaling was hypothesized to mediate this reduction because increased plasma levels of glucagon are characteristic of metabolic stress and because this hormone stimulates energy consumption linked to increased gluconeogenic flux through cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C) and associated pathways. We developed what we believe to be a novel hyperglucagonemic-euglycemic clamp to isolate an increment in glucagon levels while maintaining fasting glucose and insulin. Metabolic stress and a physiological rise in glucagon lowered the hepatic energy state and amplified AMP-activated protein kinase signaling in control mice, but these changes were abolished in glucagon receptor–null mice and mice with liver-specific PEPCK-C deletion. 129X1/Sv mice, which do not mount a glucagon response to hypoglycemia, displayed an increased hepatic energy state compared with C57BL/6 mice in which glucagon was elevated. Taken together, these data demonstrate in vivo that the hepatic energy state is sensitive to glucagon receptor activation and requires PEPCK-C, thus providing new insights into liver metabolism.

Authors

Eric D. Berglund, Robert S. Lee-Young, Daniel G. Lustig, Sara E. Lynes, E. Patrick Donahue, Raul C. Camacho, M. Elizabeth Meredith, Mark A. Magnuson, Maureen J. Charron, David H. Wasserman

×

Figure 7

Hepatic PEPCK-C is required to mediate metabolic stress– and glucagon-induced reductions in hepatic energy state.

Options: View larger image (or click on image) Download as PowerPoint
Hepatic PEPCK-C is required to mediate metabolic stress– and glucagon-in...
(A) Hepatic adenine nucleotides measured by HPLC in 5-hour-fasted 12-week-old Pcklox/lox and littermate Pcklox/loxAlb-cre mice following a hyperglucagonemic-euglycemic clamp (n = 7–9/group). Hepatic AMP/ATP ratios are shown for each group on the right. (B–E) Representative immunoblots for p-AMPKαThr172/total AMPKα, p-ACCSer79/ACC, PEPCK-C, and p-LKB1Ser428/LKB1 content. The numbers beneath each lane are arbitrary units normalized to vehicle-infused Pcklox/loxAlb-cre mice. (F) Hepatic PEPCK-C protein content relative to hepatic AMP/ATP ratios in mice from all metabolic stress and/or clamp conditions in C57BL/6, 129X1/Sv, Gcgr+/+, Gcgr–/–, Pcklox/lox, and Pcklox/loxAlb-cre mice. PEPCK-C protein content was determined by immunoblot and normalized to C57BL/6 mice in the fed state. Data are mean ± SEM. *P < 0.05 compared with all other groups.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts